TP53 and cancer: Low concentrations of DNA-damaging drugs such as doxorubicin, etoposide and actinomycin D induce p53-dependent G1 and G2 arrest in normal and cancer cells with wild type p53, protecting them from cell death caused by S-phase or M-phase specific chemotherapy [13, 16, 17].